Hapten

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

A small molecule which, although not itself, can trigger an immunological response when bound to a protein. This protein is called a carrier protein or "carrier". Haptens can be inorganic substances, lipids, nucleic acids, drugs (e.g. penicillins), etc. The carrier protein can be found in the skin, on the cell membrane of a red blood cell or platelet, etc.

Note(s)This section has been translated automatically.

The hapten/prohapten hypothesis is supplemented by the so-called p-i concept (pharmaceutical interaction with immunreceptors). This concept states that drugs can also interact directly with cell surface receptors, e.g. with T-cell receptors, and thus activate T-cells.

LiteratureThis section has been translated automatically.

  1. Pichler J (2007) Hapten model versus p-i concept. Allergo J 16: 238-239

Authors

Last updated on: 29.10.2020